BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint

A simple technique for quantitation of low levels of DNA damage in individual cells

Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828 · see citing works

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237 · see citing works

Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141 · see citing works

Cell cycle checkpoint signaling through the ATM and ATR kinases

Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966 · see citing works

Chk1 is an essential kinase that is regulated by Atr and required for the G ₂ /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · see citing works

<i>ATR</i> disruption leads to chromosomal fragmentation and early embryonic lethality

Brown, E. J., & Baltimore, D. (2000) · Genes &amp; Development · doi:10.1101/gad.14.4.397 · Cited by 951 · see citing works

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Gong, J., Costanzo, A., Yang, H., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 923 · see citing works

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

Konopka, J. B., Watanabe, S. M., & Witte, O. N. (1984) · Cell · doi:10.1016/0092-8674(84)90438-0 · Cited by 872 · see citing works

Radiosensitivity in ataxia-telangiectasia: a new explanation.

Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 794 · see citing works

Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow

Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R. T., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755 · see citing works

Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A

Sørensen, C. S., Syljuåsen, R. G., Falck, J., Schroeder, T., Rönnstrand, L., Khanna, K. K., Zhou, B.-B., Bártek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00048-5 · Cited by 560 · see citing works

Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 544 · see citing works

Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A. J., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 538 · see citing works

Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints

Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., & Friend, S. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 534 · see citing works

Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance

Brown, E. J., & Baltimore, D. (2003) · Genes &amp; Development · doi:10.1101/gad.1067403 · Cited by 511 · see citing works

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

Bedi, A., Zehnbauer, B., Barber, J. P., Sharkis, S. J., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 506 · see citing works

Interaction between ATM protein and c-Abl in response to DNA damage

Shafman, T. D., Khanna, K. K., Kedar, P. S., Spring, K. J., Kozlov, S., Yen, T. J., Hobson, K., Gatei, M. H., Zhang, N., Watters, D. J., et al. (1997) · Nature · doi:10.1038/387520a0 · Cited by 478 · see citing works

Maintenance of Genome Stability in Saccharomyces cerevisiae

Kolodner, R. D., Putnam, C. D., & Myung, K. (2002) · Science · doi:10.1126/science.1075277 · Cited by 464 · see citing works

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

Etten, R. A. V., Jackson, P. K., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 425 · see citing works

An ATR- and Cdc7-Dependent DNA Damage Checkpoint that Inhibits Initiation of DNA Replication

Costanzo, V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M. E., & Gautier, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00799-2 · Cited by 355 · see citing works

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

Vigneri, P. G., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 333 · see citing works

BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

Słupianek, A., Schmütte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M. O., Pierce, A. J., Fishel, R. A., & Skórski, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00357-4 · Cited by 313 · see citing works

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase

Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y. J., & Hope, T. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7457 · Cited by 311 · see citing works

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Ahuja, H., Bar‐Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284 · see citing works

Regulation of cell death by the Abl tyrosine kinase

Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 278 · see citing works

Defective S Phase Chromatin Assembly Causes DNA Damage, Activation of the S Phase Checkpoint, and S Phase Arrest

Ye, X., Franco, A. A., Santos, H., Nelson, D. M., Kaufman, P. D., & Adams, P. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00037-6 · Cited by 262 · see citing works

An ATR- and Chk1-Dependent S Checkpoint Inhibits Replicon Initiation following UVC-Induced DNA Damage

Heffernan, T. P., Simpson, D. A., Frank, A. R., Heinloth, A. N., Paules, R. S., Cordeiro-Stone, M., & Kaufmann, W. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8552-8561.2002 · Cited by 251 · see citing works

Radiosensitivity in ataxia-telangiectasia

Cunliffe, P. N., Mann, J. R., Cameron, A., Roberts, K. D., & Ward, H. W. C. (1975) · British Journal of Radiology · doi:10.1259/0007-1285-48-569-374 · Cited by 189 · see citing works

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Wetzler, M., Talpaz, M., Etten, R. A. V., Hirsch‐Ginsberg, C., Beran, M., & Kurzrock, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116786 · Cited by 188 · see citing works

The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf

Neshat, M. S., Raitano, A. B., Wang, H., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185 · see citing works

Determination of cell fate by c-Abl activation in the response to DNA damage

Kharbanda, S. M., Yuan, Z.-M., Weichselbaum, R. W., & Kufe, D. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202571 · Cited by 166 · see citing works

BCR-ABL down-regulates the DNA repair protein DNA-PKcs

Deutsch, É., Dugray, A., Abdulkarim, B., Marangoni, E., Maggiorella, L., Vaganay, S., M'Kacher, R., Douc‐Rasy, S., Eschwège, F., Vainchenker, W., et al. (2001) · Blood · doi:10.1182/blood.v97.7.2084 · Cited by 166 · see citing works

Initiation of Deregulated Growth of Multipotent Progenitor Cells by bcr-abl in Vitro

Gishizky, M. L., & Witte, O. N. (1992) · Science · doi:10.1126/science.1375394 · Cited by 160 · see citing works

BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

Salesse, S., & Verfaillie, C. M. (2002) · Oncogene · doi:10.1038/sj.onc.1206082 · Cited by 137 · see citing works

Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression.

Klucher, K., Lopez, D. V., & Daley, G. (1998) · Blood · doi:10.1182/blood.v91.10.3927.3927_3927_3934 · Cited by 133 · see citing works

Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression

Klucher, K. M., Lopez, D. V., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.10.3927 · Cited by 122 · see citing works

Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells

Deutsch, É., Jarrousse, S., Selimoglu‐Buet, D., Dugray, A., Bonnet, M., Vozenin, M., Guilhot, F., Turhan, A. G., Feunteun, J., & Bourhis, J. (2003) · Blood · doi:10.1182/blood-2002-10-3011 · Cited by 100 · see citing works

The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein

Takeda, N., Shibuya, M., & Maru, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.203 · Cited by 79 · see citing works

DNA damage enables p73

White, E., & Prives, C. L. (1999) · Nature · doi:10.1038/21539 · Cited by 65 · see citing works

DOES THE BCR/ABL‐MEDIATED INCREASE IN THE EFFICACY OF DNA REPAIR PLAY A ROLE IN THE DRUG RESISTANCE OF CANCER CELLS?

Majsterek, I., Błasiak, J., Mlynarski, W. M., Hoser, G., & Skórski, T. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0865 · Cited by 33 · see citing works

Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia

Grießhammer, M., Heinze, B., Bangerter, M., Heimpel, H., & Fliedner, T. M. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050173 · Cited by 30 · see citing works

Checking on DNA damage in S phase

Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758 · see citing works

Chronic myeloid leukaemia as a model of disease evolution in human cancer

Melo, J. V., & Barnes, D. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2147 · Cited by 616 · see citing works

The biology of CML blast crisis

Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 591 · see citing works

Cell Cycle Regulation of DNA Replication

Sclafani, R. A., & Holzen, T. M. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130308 · Cited by 448 · see citing works

High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy

Willis, S. G., Lange, T., Demehri, S., Otto, S., Crossman, L. C., Niederwieser, D. W., Stoffregen, E. P., McWeeney, S. K., Kovacs, I., Park, B. S., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1036 · Cited by 298 · see citing works

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks

Nowicki, M. O., Falinski, R., Koptyra, M., Słupianek, A., Stokłosa, T., Gloc, E., Nieborowska-Skorska, M., Błasiak, J., & Skórski, T. (2004) · Blood · doi:10.1182/blood-2004-05-1941 · Cited by 271 · see citing works

Cellular response to etoposide treatment

Montecucco, A., & Biamonti, G. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.11.005 · Cited by 231 · see citing works

Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia

Zhang, S., Ma, L., Huang, Q., Guo, L., Gu, B.-W., Gao, X., Shi, J.-Y., Wang, Y., Gao, L., Cai, X., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711824105 · Cited by 181 · see citing works

Applying the discovery of the Philadelphia chromosome

Sherbenou, D. W., & Druker, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31988 · Cited by 119 · see citing works

BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia

Burke, B. A., & Carroll, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.67 · Cited by 89 · see citing works

Structural Basis for the Cytoskeletal Association of Bcr-Abl/c-Abl

Hantschel, O. D., Wiesner, S., Guettler, T., Mackereth, C. D., Rix, L. L. R., Mikes, Z., Dehne, J., Görlich, D., Sattler, M., & Superti‐Furga, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.030 · Cited by 81 · see citing works

Cdc7 Is an Active Kinase in Human Cancer Cells Undergoing Replication Stress

Tenca, P., Brotherton, D. H., Montagnoli, A., Rainoldi, S., Albanese, C., & Santocanale, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604457200 · Cited by 81 · see citing works

ATR–Chk1–APC/CCdh1-dependent stabilization of Cdc7–ASK (Dbf4) kinase is required for DNA lesion bypass under replication stressPreprint

Yamada, M., Watanabe, K., Mistrík, M., Veselá, E., Protivankova, I., Mailand, N., Lee, M., Masai, H., Lukas, J., & Bartek, J. (2013) · Genes & Development · doi:10.1101/gad.224568.113 · Cited by 81 · see citing works

Cdc7 kinase – A new target for drug development

Swords, R. T., Mahalingam, D., O'Dwyer, M. E., Santocanale, C., Kelly, K. R., Carew, J. S., & Giles, F. J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.020 · Cited by 79 · see citing works

Cdc7-Dbf4 and the Human S Checkpoint Response to UVC

Heffernan, T. P., Ünsal-Kaçmaz, K., Heinloth, A. N., Simpson, D. A., Paules, R. S., Sancar, A., Cordeiro‐Stone, M., & Kaufmann, W. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611292200 · Cited by 78 · see citing works

BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells

Słupianek, A., Nowicki, M. O., Koptyra, M., & Skórski, T. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.10.005 · Cited by 75 · see citing works

Fusion tyrosine kinases: a result and cause of genomic instability

Penserga, E. T. P., & Skórski, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209756 · Cited by 75 · see citing works

Nuclear trafficking of pro-apoptotic kinases in response to DNA damage

Yoshida, K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.05.003 · Cited by 74 · see citing works

Cellular and Clinical Impact of Haploinsufficiency for Genes Involved in ATR Signaling

O’Driscoll, M., Dobyns, W. B., van Hagen, J. M., & Jeggo, P. A. (2007) · The American Journal of Human Genetics · doi:10.1086/518696 · Cited by 73 · see citing works

Signaling Networks Associated with BCR–ABL–Dependent Transformation

Hazlehurst, L., Bewry, N. N., Nair, R. R., & Pinilla-Ibarz, J. A. (2009) · Cancer Control · doi:10.1177/107327480901600202 · Cited by 69 · see citing works

The Role of Dbf4/Drf1-Dependent Kinase Cdc7 in DNA-Damage Checkpoint Control

Tsuji, T., Lau, E. K., Chiang, G. G., & Jiang, W. B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.005 · Cited by 62 · see citing works

ATR-Chk1 Axis Protects BCR/ABL Leukemia Cells from the Lethal Effect of DNA Double-Strand Breaks

Nieborowska-Skorska, M., Stokłosa, T., Datta, M., Czechowska, A., Rink, L. A., Słupianek, A., Koptyra, M., Seferyńska, I., Krszyna, K., Błasiak, J., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2722 · Cited by 59 · see citing works

TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress

Nihira, K., Taira, N., Miki, Y., & Yoshida, K. (2008) · Oncogene · doi:10.1038/onc.2008.334 · Cited by 58 · see citing works

BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair

Fernandes, M. S., Reddy, M. M., Gonneville, J. R., DeRoo, S. C., Podar, K., Griffin, J. D., Weinstock, D. M., & Sattler, M. (2009) · Blood · doi:10.1182/blood-2008-07-172148 · Cited by 58 · see citing works

Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications

Rodrigues, M. S., Reddy, M. M., & Sattler, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2071 · Cited by 57 · see citing works

The human intra-S checkpoint response to UVC-induced DNA damage

Kaufmann, W. K. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp230 · Cited by 52 · see citing works

Dbf4 Is Direct Downstream Target of Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) Protein to Regulate Intra-S-phase Checkpoint

Lee, A. Y., Chiba, T., Truong, L. N., Cheng, A. N., Do, J. P. H., Cho, M. J., Chen, L., & Wu, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291104 · Cited by 52 · see citing works

Regulation of the initiation of DNA replication in human cells

Moiseeva, T. N., & Bakkenist, C. J. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.09.003 · Cited by 51 · see citing works

Molecular Pathogenesis of MLL-Associated Leukemias

Eguchi, M., Eguchi‐Ishimae, M., & Greaves, M. F. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05042 · Cited by 50 · see citing works

Molecular architecture of the DNA replication origin activation checkpoint

Tudzarova, S., Trotter, M. W. B., Wollenschlaeger, A., Mulvey, C. M., Godovac‐Zimmermann, J., Williams, G. H., & Stoeber, K. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.201 · Cited by 49 · see citing works

Regulation and roles of Cdc7 kinase under replication stress

Yamada, M., Masai, H., & Bártek, J. (2014) · Cell Cycle · doi:10.4161/cc.29251 · Cited by 41 · see citing works

Pathobiology of Lymphoid and Myeloid Blast Crisis and Management Issues

Ilaria, R. L. (2005) · Hematology · doi:10.1182/asheducation-2005.1.188 · Cited by 41 · see citing works

Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining

Chakraborty, S., Stark, J. M., Sun, C., Modi, H., Chen, W., O'Connor, T. R., Forman, S. J., Bhatia, S., & Bhatia, R. (2012) · Blood · doi:10.1182/blood-2011-05-352252 · Cited by 40 · see citing works

Mouse models for ATR deficiency

O’Driscoll, M. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.09.001 · Cited by 40 · see citing works

ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias

Boudný, M., & Trbušek, M. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102026 · Cited by 40 · see citing works

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Abdulmawjood, B., Costa, B. G. L. D. M., Roma‐Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212516 · Cited by 36 · see citing works

Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors

Ichim, C. V. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0159 · Cited by 35 · see citing works

XenopusCdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1

Poh, W. T., Chadha, G. S., Gillespie, P. J., Kaldis, P., & Blow, J. J. (2014) · Open Biology · doi:10.1098/rsob.130138 · Cited by 35 · see citing works

14‐3‐3 Ligand Prevents Nuclear Import of c‐ABL Protein in Chronic Myeloid Leukemia

Mancini, M., Veljković, N., Corradi, V., Zuffa, E., Corrado, P., Pagnotta, E., Martinelli, G., Barbieri, E., & Santucci, M. A. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00897.x · Cited by 34 · see citing works

Drug design with Cdc7 kinase: a potential novel cancer therapy target

Masai, H. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s4303 · Cited by 34 · see citing works

BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold

Dierov, J. K., Sanchez, P. V., Burke, B. A., Padilla‐Nash, H. M., Putt, M. E., Ried, T., & Carroll, M. P. (2008) · Leukemia · doi:10.1038/leu.2008.308 · Cited by 33 · see citing works

Stem cell and kinase activity‐independent pathway in resistance of leukaemia to BCR‐ABL kinase inhibitors

Li, S., & Li, D. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00108.x · Cited by 33 · see citing works

Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells

Rink, L. A., Słupianek, A., Stokłosa, T., Nieborowska-Skorska, M., Urbańska, K., Seferyńska, I., Krzysztof Reiss, F., & Skórski, T. (2007) · Blood · doi:10.1182/blood-2006-08-042630 · Cited by 32 · see citing works

BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint

Giallongo, C., Tibullo, D., Cava, P. L., Branca, A., Parrinello, N. L., Spina, P., Stagno, F., Conticello, C., Chiarenza, A., Vigneri, P. G., et al. (2011) · Acta Haematologica · doi:10.1159/000329911 · Cited by 31 · see citing works

Genomic instability: The cause and effect of BCR/ABL tyrosine kinase

Skórski, T. (2007) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-007-0010-6 · Cited by 31 · see citing works

Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells

Turner, S. D., & Alexander, D. R. (2006) · Leukemia · doi:10.1038/sj.leu.2404125 · Cited by 31 · see citing works

Novel Role for Checkpoint Rad53 Protein Kinase in the Initiation of Chromosomal DNA Replication inSaccharomyces cerevisiae

Dohrmann, P. R., & Sclafani, R. A. (2006) · Genetics · doi:10.1534/genetics.106.060236 · Cited by 30 · see citing works

BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia: Not Quite Enough to Cause Resistance to Imatinib Therapy?

Lange, T., Park, B. S., Willis, S. G., & Deininger, M. W. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2261 · Cited by 30 · see citing works

BCR/ABL Recruits p53 Tumor Suppressor Protein to Induce Drug Resistance

Stokłosa, T., Słupianek, A., Datta, M., Nieborowska-Skorska, M., Nowicki, M. O., Koptyra, M., & Skórski, T. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1229 · Cited by 29 · see citing works

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

Kwok, M., Agathanggelou, A., & Stanković, T. (2024) · Blood · doi:10.1182/blood.2023019963 · Cited by 28 · see citing works

Graphene quantum dots decorated with imatinib for leukemia treatment

Félix, D. M., Alencar, L. M. R., de Menezes, F. D., Midlej, V. D. V. P., Aguiar, L., Piperni, S. G., Zhang, J., Liu, Y., Ricci‐Júnior, E., Alexis, F., et al. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102117 · Cited by 28 · see citing works

Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation

Wei, F., Yan, J., Tang, D., Lin, X., He, L., Xie, Y., Tao, L., & Wang, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.016 · Cited by 28 · see citing works

Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia

Singh, M. M., Irwin, M. E., Gao, Y. H., Ban, K., Shi, P., Arlinghaus, R. B., Amin, H. M., & Chandra, J. (2011) · Cancer · doi:10.1002/cncr.26621 · Cited by 27 · see citing works

Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy?

Muvarak, N. E., Nagaria, P. K., & Rassool, F. V. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0119-0 · Cited by 26 · see citing works

BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin

Słupianek, A., Gurdek, E., Koptyra, M., Nowicki, M. O., Siddiqui, K. M., Groden, J. L., & Skórski, T. (2005) · Oncogene · doi:10.1038/sj.onc.1208545 · Cited by 26 · see citing works

DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling

Sasi, N. K., Coquel, F., Lin, Y., MacKeigan, J. P., Pasero, P., & Weinreich, M. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.001 · Cited by 25 · see citing works

Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?

Tariq, I. (2006) · Frontiers in bioscience · doi:10.2741/1791 · Cited by 25 · see citing works

Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity

Skorta, I., Oren, M., Markwardt, C., Gutekunst, M., Aulitzky, W. E., & van der Kuip, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0548 · Cited by 24 · see citing works

Stress and death: breaking up the c-Abl/14-3-3 complex in apoptosis

Pendergast, A. M. (2005) · Nature Cell Biology · doi:10.1038/ncb0305-213 · Cited by 24 · see citing works

Regulation for Nuclear Targeting of the Abl Tyrosine Kinase in Response to DNA Damage

Yoshida, K. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69116-9_15 · Cited by 23 · see citing works

The DNA damage response during an unperturbed S-phase

Ben‐Yehoyada, M., Gautier, J., & Dupré, A. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.005 · Cited by 23 · see citing works

Improving detection of differentially expressed gene sets by applying cluster enrichment analysis to Gene Ontology

Xu, T., Gu, J., Zhou, Y., & Du, L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-240 · Cited by 21 · see citing works

Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes

Stetka, J., Gurský, J., Velasquez, J. L., Mojzíková, R., Vyhlidalova, P., Vráblová, L., Bártek, J., & Divoký, V. (2020) · Cancers · doi:10.3390/cancers12040903 · Cited by 19 · see citing works

Loss of CCDC6 Affects Cell Cycle through Impaired Intra-S-Phase Checkpoint Control

Thanasopoulou, A., Stravopodis, D. J., DIMAS, K. S., Schwaller, J., & Anastasiadou, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031007 · Cited by 19 · see citing works

Inhibition of DNA Damage-induced Apoptosis through Cdc7-mediated Stabilization of Tob

Suzuki, T., Kawamura-Tsuzuku, J., Hayashi, A., Shiomi, Y., Iwanari, H., Mochizuki, Y., Hamakubo, T., Kodama, T., Nishitani, H., Masai, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353805 · Cited by 18 · see citing works

Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells

Lei, H., Jin, J., Liu, M., Li, X., Luo, H., Li, Y., Xu, H., & Wu, Y. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.11.007 · Cited by 17 · see citing works

Identification of TopBP1 as a c-Abl-interacting Protein and a Repressor for c-Abl Expression

Zeng, L., Hu, Y., & Li, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503016200 · Cited by 17 · see citing works

Apoptosis Induction in MV4-11 and K562 Human Leukemic Cells by Pereskia sacharosa (Cactaceae) Leaf Crude Extract

Jusoh, S. A. M., Al‐Jamal, H. A. N., Ang, C. Y., Asan, J. M., Seeni, A., & Johan, M. F. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.475 · Cited by 16 · see citing works

Gene therapy for BCR‐ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector

Sengupta, A., Banerjee, D., Chandra, S., & Banerjee, S. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.959 · Cited by 16 · see citing works

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia—From Single Cell Analysis to Next-Generation Sequencing

Deręgowska, A., Pępek, M., Pruszczyk, K., Machnicki, M. M., Wnuk, M., & Stokłosa, T. (2020) · Genes · doi:10.3390/genes11101145 · Cited by 13 · see citing works

Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors

Martin, M. G., DiPersio, J. F., & Uy, G. L. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802517765 · Cited by 12 · see citing works

The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia

Rimmelé, P., Esposito, M., Delestré, L., Guervilly, J.-H., Ridinger-Saison, M., Despras, E., Moreau-Gachelin, F., Rosselli, F., & Guillouf, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16183 · Cited by 11 · see citing works

Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects

Senapati, J., & Sasaki, K. (2022) · Cancers · doi:10.3390/cancers14102533 · Cited by 11 · see citing works

Ataxia Telangiectasia and Rad3-Related Overexpressing Cancer Cells Induce Prolonged G 2 Arrest and Develop Resistance to Ionizing Radiation

Kim, Y.-M., Lee, Y. M., Park, S., & Pyo, H. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1141 · Cited by 10 · see citing works

Anti-Proliferative Effects of Dendrophthoe pentandra Methanol Extract on BCR/ABL-Positive and Imatinib-Resistant Leukemia Cell Lines

Zamani, A., Jusoh, S. A. M., Al‐Jamal, H. A. N., Sul’ain, M. D., & Johan, M. F. (2016) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2016.17.11.4857 · Cited by 8 · see citing works

Growth inhibition by STI571 in combination with radiation in human chronic myelogenous leukemia K562 cells

Huguet, F., Giocanti, N., Hennequin, C., Croisy‐Delcey, M., Touboul, E., & Favaudon, V. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2023 · Cited by 8 · see citing works

Src kinases as targets for Bcell acute lymphoblastic leukaemia therapy

Li, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.329 · Cited by 8 · see citing works

REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity

Lee, Y. J., Lee, S. Y., Kim, S.-M., Kim, S.-H., Lee, S. H., Park, S., Kim, J. J., Kim, D., & Kim, H. (2024) · Leukemia · doi:10.1038/s41375-024-02362-z · Cited by 7 · see citing works

Tumor Suppressor Genes in Myeloid Differentiation and Leukemogenesis

Britschgi, C., & Fey, M. F. (2009) · Future Oncology · doi:10.2217/14796694.5.2.245 · Cited by 7 · see citing works

Role of the C‐terminal actin binding domain in BCR/ABL‐mediated survival and drug resistance

Underhill-Day, N., Pierce, A., Thompson, S., Xenaki, D., Whetton, A. D., & Owen‐Lynch, P. J. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05949.x · Cited by 7 · see citing works

Replication stress response and radioresistance in lung cancer: Mechanistic insights and advanced therapeutic approaches

Kundu, M., Dey, A., & Dasgupta, S. (2025) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2025.101206 · Cited by 6 · see citing works

Mouse Models of Human Blood Cancers

Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9 · Cited by 6 · see citing works

Targeting cell cycle checkpoints for glioma therapy

Lang, F., & Yang, C. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108932 · Cited by 4 · see citing works

Chronic Myeloid Leukemia: Biology of Advanced Phase

Melo, J. V., & Barnes, D. (2007) · Springer eBooks · doi:10.1007/978-3-540-34506-0_3 · Cited by 4 · see citing works

Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia

Zhang, X., Jia, D., Ao, J., Liu, H., Zang, Y., Azam, M., Habib, S. L., Li, J., Ruan, X., Jia, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11566 · Cited by 4 · see citing works

The C-terminal tail of Rad17, iVERGE, binds the 9‒1‒1 complex independently of AAA+ ATPase domains to provide another clamp–loader interface

Fukumoto, Y., Hoshino, T., Nakayama, Y., & Ogra, Y. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103567 · Cited by 3 · see citing works

Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity

Pannucci, N. L., Li, D., Sahay, S., Thomas, E. K., Chen, R., Tala, I., Hu, T., Ciccarelli, B. T., Megjugorac, N. J., Adams, H., et al. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.36 · Cited by 3 · see citing works

the-alpha-fetoprotein-receptor-binding-fragment-localization-of-third-domain-interaction-sites-of-dna-repair-proteins/#

(2017) · Cancer Studies and Therapeutics · doi:10.31038/cst.2017232 · Cited by 3 · see citing works

Abl and Cell Death

Wang, J. Y. J., Minami, Y., & Zhu, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-68744-5_4 · Cited by 3 · see citing works

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia

Zheng, R., Wei, W., Liu, S., Zeng, D., Yang, Z., Tang, J., Tan, J., Huang, Z., & Gao, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01694-8 · Cited by 2 · see citing works

Nuclear localization of BCR and cortactin indicates their potential role in regulation of actin branching in nucleus

Gurianov, D. S., Antonenko, S. V., & Телегеев, Г. Д. (2021) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-43-no-1.15811 · Cited by 2 · see citing works

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness

Massimino, M., Stella, S., Romano, C., Buffa, P., Tirrò, E., Drago, M., Manzella, L., Tomarchio, C., Vitale, S. R., Raimondo, F. D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146591 · Cited by 2 · see citing works

Imatinib Mesylate (Gleevec®) and the Emergence of Chemotherapeuticss Drug-Resistant Mutations

Denis, G. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_22 · Cited by 2 · see citing works

Chronic Myeloid Leukaemia

Casolari, D. A., & Melo, J. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_7 · Cited by 2 · see citing works

Meeting Report: Sixth International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, May 1–4, 2005

Wolff, L., Ackerman, S. J., & Nucifora, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.09.011 · Cited by 1 · see citing works

Molecular Pathogenesis of BCR‐ABL in Chronic Myeloid Leukemia

Padron, E., Hazlehurst, L., & Pinilla-Ibarz, J. A. (2011) · Wiley eBooks · doi:10.1002/9781444394016.ch4 · Cited by 1 · see citing works

The DNA Replication Initiation Machinery as a Target for Cancer Diagnosis and Therapy

Wollenschlaeger, A. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1 · see citing works

A Perspective on the Molecular Evolution of Chronic Myeloid Leukemia from Chronic Phase to Blast Transformation

Mughal, T. I., & Goldman, J. M. (2006) · Clinical Leukemia · doi:10.3816/clk.2006.n.015 · Cited by 1 · see citing works

Getting to the root of the stem cell in mutated chronic myeloid leukemia

Larson, S. M., & Godley, L. A. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.531802 · Cited by 1 · see citing works

Modeling Human Philadelphia Chromosome-Positive Leukemia in Mice

Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9_7

BCR/ABL Expression Increases the Formation of Chromosomal Translocations after DNA Damage.

Dierov, J. K., Padilla‐Nash, H. M., Ried, T., & Carroll, M. P. (2004) · Blood · doi:10.1182/blood.v104.11.713.713 · Cited by 1 · see citing works

The Effects of BCR/ABL on DNA Damage and Repair Are Dependent on Apoptosis Competence

Burke, B. A., & Carroll, M. P. (2008) · Blood · doi:10.1182/blood.v112.11.4216.4216

BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold

Dierov, J. K., Sanchez, P. V., Burke, B. A., Padilla‐Nash, H. M., Putt, M. E., Ried, T., & Carroll, M. P. (2008) · Leukemia · doi:10.1038/leu.2008.308 · Cited by 33 · see citing works

BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia

Burke, B. A., & Carroll, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.67 · Cited by 89 · see citing works

EFFECTS OF THE BCR-ABL ONCOGENE ON DNA DAMAGE AND REPAIR

Burke, B. A., Beth, A., Brown, E. J., Johnson, F. B., Abstract, P., & Carroll, M. (2010)